Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
Sophie Davies, Training and Development Supervisor at Bespoke Clinical Services, shared a post on LinkedIn:
“One observation I’ve made during my experience as a clinical pharmacist is that patients often don’t consider supplements to be ‘medications’, so they don’t always mention them during reviews.
During some anticoagulant safety searches, I identified several patients taking omega-3/cod liver oil supplements alongside DOAC therapy.
They were all unaware of the potential additive bleeding risk.
This reinforced how important clear medicine counselling and thorough medication reviews are in reducing preventable harm.
The goal is to translate guidance into practical, usable information to keep patients fully informed.
Small interventions can have a significant impact on patient safety.”
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 14:30Alan Nurden: Honoring the Legacy of Dr. Richard Aster
-
Jun 6, 2026, 14:17Danny Hsu: A Practice-Changing Milestone in Managing Post-Thrombotic Syndrome
-
Jun 6, 2026, 13:01Kathleen Freson: αIIbβ3’s Hidden Role in Platelet Production
-
Jun 6, 2026, 12:22Jonas Kingo: Factor XI at the Crossroads of Hormonal Regulation and Thrombosis at ISTH 2026
-
Jun 6, 2026, 12:06Reza Shojaei: Why Dried Plasma May Be the Most Important Plasma Innovation in Decades
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?